On the other hand, ICIs can activate CD8+ T lymphocytes and Th1 cells to secrete anti-tumor cytokines such as interferon γ and tumor necrosis factor, which can regulate the immune microenvironment while exerting anti-angiogenic and vascular normalization effects (67, 68). The gene discussed is CD8A; the disease is neoplasm.